Studies by RNA-seq identified differential transcriptional changes in B6 vs. Irf1−/− colons following AOM/DSS revealing a much more robust and distinct inflammatory response in treated Irf1−/− mutants (sustained infiltration of inflammatory leukocytes) compared to controls (more prominent antigen presentation). The gene discussed is IRF1; the disease is infectious otitis media.